Home

Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Sell · Filed 23/08/17

Trade details

Type
Insider sale
Amount
$15,598.44
Shares · price
19,998 sh · $0.78 a share
Held after
919,799 sh
Trade date
23/08/16
Filed
23/08/17
Days to filing
1 days

Sold 2.1% of holdings

Share of holding sold
2.1%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/17~23/09/15

Howard W. Robin's recent trades

  • Howard W. Robin

    Planned saleNektar Therapeutics

    $30.1K

    Filed 08/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $334.5K

    Filed 06/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $318K

    Filed 06/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $285.2K

    Filed 06/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $277.4K

    Filed 06/18